Stay updated on TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    Added related topics for 'Multiple myeloma' and 'MedlinePlus Genetics', and updated the site revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-20T17:24:40.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision label changed from v3.4.2 to v3.4.3. This appears to be a minor backend or display update with no observable changes to the study details or page content.
    Difference
    0.1%
    Check dated 2026-03-06T17:41:44.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Removed mentions of the disease name 'Multiple Myeloma' and the related topic 'MedlinePlus Genetics' from the page content.
    Difference
    0.2%
    Check dated 2026-02-27T18:48:27.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Added Related topics: Multiple myeloma and MedlinePlus Genetics to the page.
    Difference
    0.2%
    Check dated 2026-02-20T15:33:29.000Z thumbnail image
  8. Check
    57 days ago
    Change Detected
    Summary
    A new revision label 'Revision: v3.4.2' is shown. Non-core topics such as 'Multiple myeloma' and 'MedlinePlus Genetics' appear to have been removed, replacing an earlier 'Revision: v3.4.1' label.
    Difference
    0.2%
    Check dated 2026-02-13T12:12:51.000Z thumbnail image
  9. Check
    64 days ago
    Change Detected
    Summary
    Added related topic entry 'Multiple myeloma' and MedlinePlus Genetics, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-06T09:10:58.000Z thumbnail image

Stay in the know with updates to TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.